Find a TenderAwarded

Published 21 Jul 2023, 16:56 BST

Official UK procurement notice

Generic Anti-Infective Drugs · UK public procurement notice

Authority: Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts) (NHS & healthcare)·Consortium: 2 public authorities

GoodsOpen procedure

Sectors: Medical Devices & Pharma (33) Delivery: UKWales (UKL)

Published estimate£3,390,876≈ £1.1m / year

Submissions closed 21 Aug 2023awarded 31 Jan 2024

Awarded to ACCORD-UK LTD +9 more10 awards

Contract term 3 yrsends 31 Jan 2027 · extension options published · starts 1 Feb 2024

What is being bought

Published requirement description

Generic Anti-Infective Drugs

CPV: Pharmaceutical products

The lotProcurement structure

single lot · value published

Lot #1AwardedRenewal 3 yrsPublished value£3,390,876

Contract period: 1 Feb 2024 – 31 Jan 2027 (3 yrs)

Delivery: UK, Wales

Extensions: There is a possibility to extend up to a further 24 monthsVariant bids: allowed

What it takes to win
i
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more

How bids were scored

Price: 170Social value: 15

Published sub-criteria (5)

Financial (overall cost of contract): 85
Price: 65
Price stability: 16
Minimum Order Value: 4
Social Value/Community Benefits: 15

Published award criteria (6)

Product Quality/Acceptability: Pass/Fail
Financial (overall cost of contract): 85
Social Value/Community Benefits: 15
Price: 65
Price stability: 16
Minimum Order Value: 4

Conditions of participation1

Suitability
Any supplier may be disqualified who does not respond to the following in the
requisite manner:
1. ENTERING GENERAL Qualification SUPPLIER INFORMATION NHS Wales Shared Services Partnership Procurement Services utilizes Sell2Wales to manage and assess general prequalification information in the form of a profile.
Candidates are requested to Register company information on the Sell2Wales website at ww.sell2wales.co.uk.
1. SUBMISSION OF TENDER AND PROCUREMENT SPECIFIC INFORMATION
(i)Candidates should register on the NHS Wales Shared Services Partnership Procurement Services eTendering portal etenderwales.bravosolution.co.uk/nhs ↗
(ii) Once registered, candidates must submit their tender as follows a) login to NHS Wales Shared Services Partnership Procurement Services eTendering portal b) select 'Respond to OJEU advert and ITT c) select 'ITTs Open To All Suppliers' d) access listing relating to the contract (title Lenalidomide) and view details e) click on 'Express Interest' button in the 'Actions' box on the left hand side of the page
(iii) Once you have expressed interest, the ITT will move to 'My ITTs', where you can download additional documentation and where you can construct your reply as instructed. You must then publish your reply using the publish button
(iv) For any support in submitting your tender, please contact the eTendering helpdesk on 08000112470 or at [email protected]

What this means for your bid

Price carries 170 of 185 points: a 10% discount moves about 17 points. This one is won on the number: sharpen the price before polishing the prose.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record · publisher note attached

Procedure method: Open procedure
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Competitive procedure
GPA / WTO covered: Unspecified in notice
Recurring procurement: Yes
First published: 21 Jul 2023, 16:56 BST
Last source update: 19 Mar 2024, 22:21 GMT
Award evaluation window: 21 Aug 2023 – …
Authority reference: PAD-OJEU-53556
FTS notice number: 2024/S 000-008924
Classification (CPV): Pharmaceutical products
Delivery area: UKWales (UKL)
Official registry OCID: ocds-h6vhtk-03e479 Find a Tender

Publisher note: 1. The contracting authority reserves the right to use an electronic reverse auction. 2. If and when this requirement is offered for tender, this may be done in whole or in part via electronic means using the internet. 3. The contracting authority is not bound to award a contract in whole or part. 4. The contracting authority will not bear the tender costs of any of the tenderers. 5. In reference to I.1.9 (Variants) to the extent permitted, if at all, in the tender documents. 6. This notice is being placed by NHS Wales Shared Services Partnership – Procurement Services. For the purpose of this procurement, the awarding authority will be Velindre NHS Trust. 7. This advertisement is placed by NHS Wales Shared Services Partnership - Procurement Services on behalf of participating LHB's/Trusts in Wales for the totality of those LHB/Trust specific contractual arrangements.

How it was run

Official notice

Run through: Jaggaer · Who buys & how to bid on Sell2Wales

Supplier login requiredLanguage: EN

Access & registration note: Free; latest Chrome/Edge/Firefox only — corporate browsers fail

Tender documents are also served through a separate tool: http://www.etenderwales.bravosolution.co.uk/nhs/ ↗

Submission deadline: 21 Aug 2023, 10:00 BST
Submission channel: {"electronicSubmission","written"}
Accepted languages: en
Participation fee: document
Bids opened: 21 Aug 2023, 10:01 BST

Detailed submission instructions & authority contactsFrom official release

www.etenderwales.bravosolution.co.uk/nhs/ ↗

Timeline

21 Aug 2023 → 19 Mar 2024 · 4 dates

Submission deadline
21 Aug 2023, 10:00 BST
Bids opened
21 Aug 2023, 10:01 BST
Contract starts
1 Feb 2024
Notice published
19 Mar 2024, 22:21 GMT

Notice history

2 events · 2 releases on Find a Tender · since 19 Mar 2024

Status changed to complete
19 Mar 2024, 22:21 GMT
Buyer details updated
19 Mar 2024, 22:21 GMT

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 27

Awarded value £9,376,98020 contracts exc. VAT

Bids received 33

Contracts signed 20latest 31 Jan 2024

Awarded to	Value	Date	Status
ACCORD-UK LTD	£424,426 †	—	Awarded
Glaxo Smithkline	£42,288 †	—	Awarded
hameln pharma ltd	£147,543 †	—	Awarded
Hikma PharmaceuticalsSME	£81,639 †	—	Awarded
Iroko Cardio	£689,520 †	—	Awarded
Kent Pharmaceuticals Ltd	£1,470,182 †	—	Awarded
Martindale	£575,169 †	—	Awarded
Mercury Pharmaceuticals Limited	£917,823 †	—	Awarded
Morningside Pharmaceuticals Limited	£123,283 †	—	Awarded
Neon Healthcare	£96,415 †	—	Awarded

17 further award records carry no date or value.

Contracts

Generic Anti-Infective Drugs · ACCORD-UK LTD
Signed
31 Jan 2024
Value
£424,426
Period
… – 31 Jan 2027
Status
active
Generic Anti-Infective Drugs · Glaxo Smithkline
Signed
31 Jan 2024
Value
£42,288
Period
… – 31 Jan 2027
Status
active
Generic Anti-Infective Drugs · hameln pharma ltd
Signed
31 Jan 2024
Value
£147,543
Period
… – 31 Jan 2027
Status
active
Generic Anti-Infective Drugs · Hikma PharmaceuticalsSME
Signed
31 Jan 2024
Value
£81,639
Period
… – 31 Jan 2027
Status
active
Generic Anti-Infective Drugs · Iroko Cardio
Signed
31 Jan 2024
Value
£689,520
Period
… – 31 Jan 2027
Status
active
Generic Anti-Infective Drugs · Kent Pharmaceuticals Ltd
Signed
31 Jan 2024
Value
£1,470,182
Period
… – 31 Jan 2027
Status
active
Generic Anti-Infective Drugs · Martindale
Signed
31 Jan 2024
Value
£575,169
Period
… – 31 Jan 2027
Status
active
Generic Anti-Infective Drugs · Mercury Pharmaceuticals Limited
Signed
31 Jan 2024
Value
£917,823
Period
… – 31 Jan 2027
Status
active
Generic Anti-Infective Drugs · Morningside Pharmaceuticals Limited
Signed
31 Jan 2024
Value
£123,283
Period
… – 31 Jan 2027
Status
active
Generic Anti-Infective Drugs · Neon Healthcare
Signed
31 Jan 2024
Value
£96,415
Period
… – 31 Jan 2027
Status
active
Generic Anti-Infective Drugs
Signed
31 Jan 2024
Value
£14,277
Period
… – 31 Jan 2027
Status
active
Generic Anti-Infective Drugs
Signed
31 Jan 2024
Value
£3,072,886
Period
… – 31 Jan 2027
Status
active
Generic Anti-Infective Drugs
Signed
31 Jan 2024
Value
£3,226
Period
… – 31 Jan 2027
Status
active
Generic Anti-Infective Drugs
Signed
31 Jan 2024
Value
£213,548
Period
… – 31 Jan 2027
Status
active
Generic Anti-Infective Drugs
Signed
31 Jan 2024
Value
£132,982
Period
… – 31 Jan 2027
Status
active
Generic Anti-Infective Drugs
Signed
31 Jan 2024
Value
£227,162
Period
… – 31 Jan 2027
Status
active
Generic Anti-Infective Drugs
Signed
31 Jan 2024
Value
£420,202
Period
… – 31 Jan 2027
Status
active
Generic Anti-Infective Drugs
Signed
31 Jan 2024
Value
£312,222
Period
… – 31 Jan 2027
Status
active
Generic Anti-Infective Drugs
Signed
31 Jan 2024
Value
£323,948
Period
… – 31 Jan 2027
Status
active
Generic Anti-Infective Drugs
Signed
31 Jan 2024
Value
£88,240
Period
… – 31 Jan 2027
Status
active

Bid statistics published by the authority

Bids	SME	VCSE	Valid bid range
33bids	—	—	—

Contracting authority & participating public bodies

2 public bodies on the notice

Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)

Contracting authorityNHS & healthcareBody governed by public lawHealth Procurement Services, Cardiff, Wales, CF14 3UZContact name, email, phone

Consortium members and other public bodies

eTenderwalesContracting authorityCentral purchasing bodyBody governed by public lawHealth Cardiff, UKContact name, email, phone Published organisation website ↗

Dispute resolution & review bodies

NHS Wales Shared Services Partnership - Procurement Services (as hosted by Velindre NHS Trust)Review body Cardiff

Bidders & participating suppliers

27 commercial parties on the notice

Accord-UKAwarded supplier North Devon, UK
Aurobindo (Milpharm)Awarded supplier Middlesex, UK
Baxter HealthcareAwarded supplier Berkshire, UK
Bowmed IbisqusAwarded supplier Wrexham, UK
CST PharmaAwarded supplier Walsall, UK
Consilient HealthAwarded supplier Surrey, UK
Crescent PharmaAwarded supplier Hampshire, UK
Esteve PharmaceuticalsAwarded supplier Berkshire, UK
Fresenius KabiAwarded supplier Cheshire, UK
Glaxo SmithklineAwarded supplier Middlesex, UK

Show 17 more suppliers

Hameln PharmaAwarded supplier Gloucester, UK
Hikma PharmaceuticalsAwarded supplier London, UK
Iroko CardioAwarded supplier London, UK
Kent PharmaceuticalsAwarded supplier Kent, UK
MartindaleAwarded supplier Essex, UK
Mercury PharmaceuticalsAwarded supplier London, UK
Morningside PharmaceuticalsAwarded supplier Leicestershire, UK
Neon HealthcareAwarded supplier Hertfordshire, UK
Pfizer LimitedAwarded supplier Surrey, UK
RPH PharmaceuticalsAwarded supplier Cheadle, UK
SandozAwarded supplier Surrey, UK
SanofiAwarded supplier Berkshire, UK
Selective SuppliesAwarded supplier Herts, UK
SunPharmaAwarded supplier Uxbridge, UK
Teva UKAwarded supplier West Yorkshire, UK
Viatris UK HealthcareAwarded supplier Herts, UK
WockhardtAwarded supplier Wrexham, UK

Official documents & specifications (2)

Official links; attachments are not copied

Tender pack and attachments

Economic and financial selection criteriatenderEconomic and financial selection criteria
Technical selection criteriatenderTechnical selection criteria